Abstract 12
Background: D-arabinitol is a metabolite of most pathogenic Candida species. Both D-arabinitol and L-arabinitol are present in normal urine, and can easily be determined by gas chromatography of urine samples collected on filter paper. An elevated urine DA/LA-ratio is a sensitive early sign of invasive candidiasis in children with cancer (J Clin Microbiol 1997;35:636-640), but the method has not previously been evaluated in newborn infants.
Patients and measurements: We measured urine DA/LA ratio in 40 healthy full-term infants, 0-3 days of age, and in 77 hospitalized infants in the neonatal intensive care unit (gestational age 25-41 weeks, 184 samples), in whom invasive candidiasis was not suspected and no systemic antifungal treatment given. DA/LA ratio was also measured in five infants treated with fluconazole, two of whom had growth of Candida in deep locations.
Results: Urine DA/LA ratio was 2.5±0.6 in the healthy newborns and 2.8±0.9 in the hospitalized infants without systemic candidiasis (mean±SD). We used a ratio of 4.6 (mean + 2SD in hospitalized infants) as the upper normal limit. All five infants treated with fluconazole had at least one DA/LA ratio above 4.6. Three infants, including one with verified candidemia, had repeatedly elevated DA/LA ratios (maximum 10.2), which returned to normal after fluconazole treatment.
Conclusion: Urine DA/LA ratios can be used in diagnosing invasive candidiasis and in monitoring the effect of antifungal treatment in sick newborn infants.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sigmundsdóttir, G., Björklund, L., Christensson, B. et al. Urine D-Arabinitol/L-Arabinitol (DA/LA) Ratio in the Diagnosis of Invasive Candidiasis in Newborn Infants. Pediatr Res 45, 889 (1999). https://doi.org/10.1203/00006450-199906000-00030
Issue Date:
DOI: https://doi.org/10.1203/00006450-199906000-00030